COMP <GO>
HLF vs MRK // NET PROFIT MARGIN
Herbalife Ltd. (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: HLF 5
— MRK 8
▲ NET PROFIT MARGIN LEADER: MRK
LAST: $13.05 (+0.93%) • MKT CAP: $1.36B
net-margins
4.50%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HLF VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HLF | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.90% | 74.80% | +3.10 | HLF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 34.40% | 20.70% | +13.70 | HLF | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.4x | 15.3x | -9.90 | HLF | /valuation <GO> |
| Free Cash Flow Yield | 18.66% | 3.42% | +15.24 | HLF | /fcf-yield <GO> |
| Operating Margin | 9.50% | 34.30% | -24.80 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 4.50% | 28.10% | -23.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 1.30% | -0.40 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.39 | 5.19 | -2.80 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 51.7 | -6.00 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 5.5x | 18.4x | -12.90 | HLF | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.36B | $361.02B | -$359.67B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HLF REV | MRK REV | HLF GROSS % | MRK GROSS % | HLF FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.04B | $65.01B | 77.9% | 74.8% | $252.9M | $12.36B |
| FY 2024 | $4.99B | $64.17B | 77.9% | 76.3% | $163.4M | $18.10B |
| FY 2023 | $5.06B | $60.12B | — | — | $357.5M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HLF // BETA —
MRK // BETA 0.92